211 related articles for article (PubMed ID: 25120763)
21. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
22. Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature.
Peckova K; Martinek P; Ohe C; Kuroda N; Bulimbasic S; Condom Mundo E; Perez Montiel D; Lopez JI; Daum O; Rotterova P; Kokoskova B; Dubova M; Pivovarcikova K; Bauleth K; Grossmann P; Hora M; Kalusova K; Davidson W; Slouka D; Miroslav S; Buzrla P; Hynek M; Michal M; Hes O
Ann Diagn Pathol; 2015 Aug; 19(4):261-8. PubMed ID: 26031603
[TBL] [Abstract][Full Text] [Related]
23. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
24. Renal Cell Carcinoma With Chromosome 6p Amplification Including the TFEB Gene: A Novel Mechanism of Tumor Pathogenesis?
Williamson SR; Grignon DJ; Cheng L; Favazza L; Gondim DD; Carskadon S; Gupta NS; Chitale DA; Kalyana-Sundaram S; Palanisamy N
Am J Surg Pathol; 2017 Mar; 41(3):287-298. PubMed ID: 28009604
[TBL] [Abstract][Full Text] [Related]
25. Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma.
Voss MH; Molina AM; Chen YB; Woo KM; Chaim JL; Coskey DT; Redzematovic A; Wang P; Lee W; Selcuklu SD; Lee CH; Berger MF; Tickoo SK; Reuter VE; Patil S; Hsieh JJ; Motzer RJ; Feldman DR
J Clin Oncol; 2016 Nov; 34(32):3846-3853. PubMed ID: 27601542
[TBL] [Abstract][Full Text] [Related]
26. Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm.
Chen YB; Mirsadraei L; Jayakumaran G; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE
Am J Surg Pathol; 2019 Jan; 43(1):121-131. PubMed ID: 30303819
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
[No Abstract] [Full Text] [Related]
28. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
29. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.
Kanayama H; Lui WO; Takahashi M; Naroda T; Kedra D; Wong FK; Kuroki Y; Nakahori Y; Larsson C; Kagawa S; Teh BT
J Med Genet; 2001 Mar; 38(3):165-70. PubMed ID: 11238683
[TBL] [Abstract][Full Text] [Related]
30. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis.
Presti JC; Moch H; Reuter VE; Cordon-Cardo C; Waldman FM
J Urol; 1996 Jul; 156(1):281-5. PubMed ID: 8648824
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies.
Vieira J; Henrique R; Ribeiro FR; Barros-Silva JD; Peixoto A; Santos C; Pinheiro M; Costa VL; Soares MJ; Oliveira J; Jerónimo C; Teixeira MR
Genes Chromosomes Cancer; 2010 Oct; 49(10):935-47. PubMed ID: 20629095
[TBL] [Abstract][Full Text] [Related]
32. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?
Hes O; Condom Mundo E; Peckova K; Lopez JI; Martinek P; Vanecek T; Falconieri G; Agaimy A; Davidson W; Petersson F; Bulimbasic S; Damjanov I; Jimeno M; Ulamec M; Podhola M; Sperga M; Pane Foix M; Shelekhova K; Kalusova K; Hora M; Rotterova P; Daum O; Pivovarcikova K; Michal M
Am J Surg Pathol; 2016 May; 40(5):664-75. PubMed ID: 26999503
[TBL] [Abstract][Full Text] [Related]
33. Distinct Genomic Copy Number Alterations Distinguish Mucinous Tubular and Spindle Cell Carcinoma of the Kidney From Papillary Renal Cell Carcinoma With Overlapping Histologic Features.
Ren Q; Wang L; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
Am J Surg Pathol; 2018 Jun; 42(6):767-777. PubMed ID: 29462091
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous heterogenotypic renal cell carcinoma: immunohistochemical and karyoptic analysis by comparative genomic hybridization.
Cho NH; Kim S; Ha MJ; Kim HJ
Urol Int; 2004; 72(4):344-8. PubMed ID: 15153736
[TBL] [Abstract][Full Text] [Related]
35. Strength of molecular cytogenetic analyses for adjusting the diagnosis of renal cell carcinomas with both clear cells and papillary features: a study of three cases.
Haudebourg J; Hoch B; Fabas T; Cardot-Leccia N; Burel-Vandenbos F; Vieillefond A; Amiel J; Michiels JF; Pedeutour F
Virchows Arch; 2010 Sep; 457(3):397-404. PubMed ID: 20567845
[TBL] [Abstract][Full Text] [Related]
36. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
[TBL] [Abstract][Full Text] [Related]
37. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
[TBL] [Abstract][Full Text] [Related]
38. Unclassified renal cell carcinoma: impact on survival following nephrectomy.
Crispen PL; Tabidian MR; Allmer C; Lohse CM; Breau RH; Blute ML; Cheville JC; Leibovich BC
Urology; 2010 Sep; 76(3):580-6. PubMed ID: 20223503
[TBL] [Abstract][Full Text] [Related]
39. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity.
Shi SS; Shen Q; Xia QY; Tu P; Shi QL; Zhou XJ; Rao Q
Int J Clin Exp Pathol; 2013; 6(12):2936-42. PubMed ID: 24294381
[TBL] [Abstract][Full Text] [Related]
40. Analysis of kidney tumors by comparative genomic hybridization and conventional cytogenetics.
Rigola MA; Casadevall C; Bernués M; Caballín MR; Fuster C; Gelabert A; Egozcue J; Miró R
Cancer Genet Cytogenet; 2002 Aug; 137(1):49-53. PubMed ID: 12377413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
